Uncategorized
Acucela to Present at the Biotech Showcase™ 2016 in San Francisco
SEATTLE--(BUSINESS WIRE)--Acucela Inc. (TOKYO: 4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, today announced that Ryo Kubota, MD, PhD, Chairman, President and CEO, will present this week at the 8th Annual Biotech Showcase™ 2016 in San Francisco, CA. Biotech Showcase™ 2016, one of the industry’s largest annual healthcare investor conferences
